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Abstract
Introduction: Bartonella spp. infection is not rare and must be considered with great care in patients
with suspected infective endocarditis, particularly if regular blood cultures remain sterile.
Management of these infections requires knowledge of the identification and treatment of these
bacteria.
Case presentation: A 50-year-old Senegalese man was admitted to our Department of Cardiac
Surgery with a culture-negative endocarditis. Despite valvular surgery and adequate antibiotic
treatment, recurrence of the endocarditis was observed on the prosthetic mitral valve. Heart failure
required circulatory support. Weaning off the circulatory support could not be attempted owing to
the absence of heart recovery. Bacteriological diagnosis of Bartonella quintana endocarditis was
performed by molecular methods retrospectively after the death of the patient.
Conclusions: This case report underlines the severity and difficulty of the diagnosis of Bartonella
quintana endocarditis. The clinical picture suggested possible Bartonella quintana associated
myocarditis, a feature that should be considered in new cases.
Introduction
Bartonella quintana is a Gram-negative bacterium first
identified as the cause of louse-borne epidemic trench fever
in Europe during World War One. Additional manifestations
of B. quintana infection including endocarditis, bacillary
angiomatosis, chronic bacteremia and pericarditis have been
reported [1]. B. quintana infection is an important cause of
culture-negative endocarditis [2]. We report a patient with
B. quintana endocarditis followed by a myocardial dysfunc-
tion which may evoke fulminant myocarditis.
Case presentation
A 50-year-old Senegalese man was hospitalized for a
6-month history of dyspnea, fever and 7 kg weight loss.
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infarction 4 years earlier. No valvulopathy was reported.
He testified to good living conditions in Senegal and
denied homelessness and substantial alcohol use.
Transthoracic echocardiography revealed major aortic and
mitral regurgitations, aortic and mitral vegetation, a mitral
chordal rupture, systolic pulmonary arterial pressure
(SPAP) at 60 mmHg and a left ventricle ejection fraction
(LVEF) of 45% with apical and septal akinesia (Figure 1).
A coronary angiogram revealed no significant stenosis
except for a left circumflex artery occlusion. Pre-operative
tomodensitometry showed two disseminated septic
emboli in the left cerebral cortex and in the left kidney.
Initial blood cultures remained negative. Thus, an empiric
antibiotic treatment with amoxicillin (12 g daily intrave-
nously) and gentamicin (200 mg daily intravenously) was
started. Aminoglycoside peak concentration was moni-
tored daily and the dose adjusted. The hemodynamic
pattern of the patient required bioprosthetic aortic and
mitral valve replacement with a cardiopulmonary bypass
3 days after his admission.
On initial admission to the surgical intensive care unit,
his hemodynamic status was stable with blood pressure at
130/60 mmHg with epinephrine 0.8 mg/hour and dobu-
tamine 12 µg/kg/minute. Weaning from the mechanical
ventilation was successful at the 6th postoperative hour.
Progressively, a right ventricle failure appeared (right
ventricle hypokinesia, SPAP of 45 mmHg at echocardio-
graphy) with renal andhepatic dysfunction (oliguria, blood
urea nitrogen level of 10 mmol/L, creatinine level of
183 µmol/L, alanine aminotransferase (ALAT) level of
20IU/L,aspartateaminotransferase(ASAT)levelof309IU/L,
bilirubin level of 40 mg/dL) and a troponin Ic level of
159 IU/L on the second postoperative day. Thereafter,
cardiogenic shock was observed. Serial cardiac enzymes
were consistent with major myocardial injury (troponin
Ic >500 IU/L). Right heart catheterization confirmed
myocardial dysfunction (pulmonary artery occlusion
pressure 25 mmHg, cardiac index 1.5 L/min/m
2). Thus,
extracorporeal membrane oxygenation (ECMO) with a
cardio-pulmonary bypass was set up as a bridge to heart
recovery. Despite circulatory support, inhaled nitric oxide
and continuous veno-venous hemodiafiltration, hemo-
dynamic status remained precarious (blood pressure at
90/40 mmHg with epinephrine 3.5 mg/hour and dobu-
tamine 10 µg/kg/minute). Echocardiography showed a
LVEF of 35%, low left and right filling pressures, and good
function of the prosthetic valves without any regurgitation.
During the following days, no heart recovery was
observed. Onthe fourth day, hepatic function dramatically
worsened with severe hypoglycemia, international nor-
malized ratio of 0.18, ALAT level of 1440 IU/L, ASAT level
of 2574 IU/L and a bilirubin level of 394 mg/dL. Serial
transthoracic echocardiography showed a decrease in
the LVEF at 25% and development of large vegetations
attached to the prosthetic mitral valve (Figure 2). The
patient died of refractory cardiac arrest on the 10th day.
Figure 1. Pre-operative transthoracic echocardiography
showing mitral vegetation and mitral chordal rupture.
Figure 2. Transthoracic echocardiography showing large
vegetations attached to the prosthetic mitral valve.
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negative. Microbiologic examination of the excised valves
showed noorganism on Gramstain and nobacteriological
growth. Microimmunofluorescence serologies performed
on two samples of serum drawn on day 1 and on day
8 remained negative for Bartonella spp. (Immunoglobulin
G titer <1:100), Coxiella spp., Chlamydia spp., Mycoplasma
spp., Legionella spp. and Bosea vestrii.T h eW e s t e r n
immunoblotting profile suggested a Bartonella spp. endo-
carditis. On the mitral resected cardiac valve, a broad range
polymerase chain reaction (PCR) targeting the 16S
ribosomal RNA gene identified a Bartonella quintana
endocarditis and species-specific PCR amplification target-
ing the 16S-23S ribosomal DNA intergenic spacer region
gene of Bartonella quintana confirmed this diagnosis. Thirty
days after admission to the surgical intensive care unit,
Bartonella quintana grewin ablood culture. However,those
results were obtained after the death of the patient.
Permission for an autopsy was refused.
Discussion
In developed countries, B. quintana endocarditis is con-
fined to specific groups, for example, body-louse infected,
alcoholic, homeless and HIV-infected individuals. In
France, Bartonella spp. account for 3% to 4% of infective
endocarditis [3]. A north to south gradient in the
distribution of this infection has been reported. Africa is
still considered to be endemic for B. quintana infections
[4,5]. Our patient was Senegalese and lived in Dakar but
had no other known risk factors for B. quintana infections.
Most reported cases of B. quintana endocarditis have
affected native valves. Few cases of prosthetic valve
endocarditis have been reported [6-8]. We report the first
case of native valve endocarditis followed by immediate
recurrence on a bioprosthetic valve despite adequate
antibiotic treatment. We did not observe rapid progression
of valvular stenosis as has been described but the rapid
development of large vegetation [7].
The cardiac failure and troponin level that we observed
were consistent with major myocardial dysfunction. This
dysfunction was probably not a complication of the
cardiopulmonary bypass usually observed no more than
several hours after the surgery. Furthermore, vasopressor
requirement was very low in the first postoperative hours.
The patient’s hemodynamic profile did not suggest septic
shock. Thus, we assumed that this dysfunction was due to
a direct infection of the myocardium as can be seen in
fulminant myocarditis. Bartonella henselae myocarditis
affecting humans has been reported [9] and a direct
infection of myocardial tissue due to B. quintana was
suspected in a case report [1]. However, in our patient, a
biopsy of the myocardium or post-mortem examination
was not carried out. Myocarditis could not be confirmed. If
B. quintana myocardial infection could be proved, it would
argue in favor of an aggressive treatment of B. quintana
induced cardiac failure associating inotropic support and
circulatory support until heart recovery.
As we observed, bacteriological diagnosis is difficult and
often retrospective. Indeed Bartonella spp. are fastidious
growing bacteria. Blood or resected valve cultures remain
negative for at least 10 days. In the case of blood culture-
negative endocarditis, the first screening must include at
least Bartonella spp. and C. burnetii serologies. Usually
microimmunofluorescence serology has a high predictive
value for the diagnosis of Bartonella spp. endocarditis if a
cut-off value of 1:800 for Bartonella spp. Immunoglobulin
G titer is used [10]. In very few cases, as in this report, this
technique fails to achieve a diagnosis [10]. Western
immunoblotting is usually more sensitive than micro-
immunofluorescence and allows a specific Bartonella
species diagnosis when coupled with cross-adsorption
[11]. In our patient, the western immunoblotting profile
suggested a Bartonella spp. endocarditis. Cross-adsorption
was not realized because this technique required a large
amount of antigens and the species identification was
already established by two different PCR assays performed
on the cardiac valve sample. In the case of negative
serologies, broad-range PCR followed by sequencing
performed on cardiac valve samples could help in the
etiological diagnosis as this molecular technique allows
the detection of numerous bacterial agents. In the case of
positive broad-range PCR, species specific PCR should be
applied to confirm the diagnosis. The usefulness of
molecular techniques in blood is still debated. But their
development would be helpful in guiding initial therapy
in patients who do not undergo emergency valvular
surgery [2].
B. quintana endocarditis treatment is non-specific. As in
our patient, the delay in diagnosis may provoke serious
valve destruction requiring its replacement. More than
90% of patients with B. quintana endocarditis require
cardiac surgery [12]. Bartonella spp. are susceptible in vitro
to a wide range of agents including penicillins, cephalos-
porins, aminoglycosides, chloramphenicol, tetracyclines,
macrolides, rifampicin, fluoroquinolones and cotrimox-
azole. However, aminoglycosides are currently the only
known antibiotic class bactericide for Bartonella spp. [13].
Patients treated with aminoglycosides for more than
14 days are more likely to survive than those under
therapy for a shorter duration [12]. That is the reason why
culture-negative endocarditis treatment should associate
a-lactamins for 6 weeks and gentamicin intravenously for
2 weeks [14]. In this case report, the choice of ceftriaxone,
recommended by the American Heart Association, would
probably not have changed the prognosis because it has
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amoxicillin [15]. If Bartonella spp. endocarditis had been
suspected, doxycycline could have been added [13]. Given
the organ dysfunctions, the persistent sepsis and the
disseminated septic emboli, a heart transplant was
rejected. This patient died of cardiac failure. Despite
adequate antibiotic treatment and valvular surgery, the
mortality rate of B. quintana endocarditis remains about
12% [12].
Conclusion
Bartonella spp. infection is not rare and must be considered
with great care in the case of patients with suspected
infective endocarditis, particularly if regular blood cultures
remain sterile despite absence of antibiotic treatment.
African origin should be considered by itself as a risk factor
for Bartonella infection. Owing to the high death rate and
the difficult diagnosis, culture-negative endocarditis
should include aminoglycoside therapy, the only anti-
biotic treatment bactericide for Bartonella spp., for at least
14 days.
The cardiac failure we observed may evoke fulminant
myocarditis. Myocardial biopsy could be decisive to
determine whether Bartonella quintana should be included
among the myocarditis infectious agents.
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